0001415889-21-004258.txt : 20210903 0001415889-21-004258.hdr.sgml : 20210903 20210903214945 ACCESSION NUMBER: 0001415889-21-004258 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210902 FILED AS OF DATE: 20210903 DATE AS OF CHANGE: 20210903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cozzens Todd C CENTRAL INDEX KEY: 0001382487 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 211238106 MAIL ADDRESS: STREET 1: ONE FEDERAL STREET STREET 2: 25TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 form4-09032021_060935.xml X0306 4 2021-09-02 0001604821 Natera, Inc. NTRA 0001382487 Cozzens Todd C C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 true false false false Common Stock 2021-09-02 4 M 0 2733 1.3855 A 15723 D Common Stock 2021-09-02 4 M 0 11169 11.80 A 26892 D Common Stock 2021-09-02 4 M 0 10578 10.41 A 37470 D Common Stock 2021-09-02 4 S 0 8841 120.9623 D 28629 D Common Stock 2021-09-02 4 S 0 10666 121.9634 D 17963 D Common Stock 2021-09-02 4 S 0 4764 122.7058 D 23865 D Stock Option (right to buy) 1.3855 2021-09-02 4 M 0 2733 0 D 2023-04-17 Common Stock 2733 0 D Stock Option (right to buy) 11.80 2021-09-02 4 M 0 11169 0 D 2026-06-09 Common Stock 11169 0 D Stock Option (right to buy) 10.41 2021-09-02 4 M 0 10578 0 D 2027-06-08 Common Stock 10578 591 D The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.48 to $121.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.50 to $122.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.50 to $123.1050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option shares vested fully and became exercisable on March 21, 2021. The option shares vested fully and became exercisable on May 23, 2017. The option shares vested fully and became exercisable on May 16, 2018. /s/ Tami Chen, Attorney-in-Fact 2021-09-03